Healthcare / Medical Care FacilitiesBSE
$111.85
-2.25 (-1.97%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $6.5M · quality 41.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$8.1B
P/E
33.7x
↑EV/EBITDA
28.7x
↑ROE
41.3%
↑Gross Margin
60.9%
↑Debt/Equity
0.45
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+24.6%
FCF CAGR
—
FCF margin
-0.2%
FCF / Net income
-0.01x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $707.2M · net income $191.3M · FCF $-1.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $707.2M | $707.2M | $478.9M | $442.4M | $365.2M |
| Net Income | $191.3M | $191.3M | $103.2M | $135.2M | $88.3M |
| EBITDA | $288.6M | $288.6M | $195.4M | $200.9M | $134.2M |
| EPS | 2.63 | 2.63 | 1.42 | 1.86 | 1.11 |
| Gross Margin | 60.9% | 60.9% | 66.8% | 68.1% | 60.5% |
| Operating Margin | 38.2% | 38.2% | 36.7% | 42.4% | 34.4% |
| Net Margin | 27.0% | 27.0% | 21.5% | 30.6% | 24.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.45 | 0.45 | 0.64 | 0.51 | 0.64 |
| Current Ratio | 1.90 | 1.90 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-1.6M | $-1.6M | $6.5M | $86.0M | $-23.7M |
| Returns | |||||
| ROE | 41.3% | 41.3% | 38.2% | 59.5% | 95.0% |
| Valuation | |||||
| P/E | 33.69 | 33.69 | — | — | — |
| EV/EBITDA | 28.67 | 28.67 | — | — | — |
| P/B | 17.58 | 17.58 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 47.7% | 47.7% | 8.3% | 21.1% | — |
| EPS Growth | 85.4% | 85.4% | -23.7% | 67.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
55.7%
EPS terminal req.
$9.92
Spread vs growth
29.7%
5Y implied EPS CAGR
35.5%
EPS terminal req.
$12.01
Spread vs growth
49.9%
10Y implied EPS CAGR
22.1%
EPS terminal req.
$19.34
Spread vs growth
63.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+37.1%
Start / end P/E
57.6x → 42.6x
EPS bridge
1.42 → 2.63
Residual
-22.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.